India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

Obesity in India is a family problem, not an individual one, with sedentary lifestyles and unhealthy diets leading to weight ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

Kombucha's popularity in India grows, but scientific evidence lags; new study explores gut microbiome effects for health.

A recent study reveals that nearly 20% of Indian households have all adults classified as overweight, while 10% are obese.

Novo Nordisk is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster ...

According to a study in The Lancet, over 14.4 million children in India are obese, making the country home to the ...

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

A new study analyzing NFHS-5 data reveals India’s most obese state. With alarming obesity rates across cities, experts warn ...